Gyre Therapeutics
GYRE
#5622
Rank
C$1.37 B
Marketcap
$14.72
Share price
19.95%
Change (1 day)
-40.07%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.02. In 2023 the company made an earnings per share (EPS) of -$2.02 a decrease over its 2022 EPS that were of $0.006242.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107.1%
2023-$2.02-32451.8%
2022$0.006242-90.93%
2021$0.06878